Headline
The latest stories from AHA Today.
The Agency for Healthcare Research and Quality has issued a request for nominations for candidates to serve on the U.S. Preventive Services Task Force.
The Food and Drug Administration April 29 announced results from its testing of more than 300 infant formulas, finding that the majority of samples had undetectable or very low levels of contaminants, deeming the U.S. supply to be safe.
University of Illinois Chicago’s Pauline Maki, Ph.D., professor of psychiatry, psychology, and obstetrics and gynecology, and Makeba Williams, M.D., professor in the Department of Obstetrics and Gynecology, unpack why menopause care is finally having a breakthrough moment. They explore the real…
Applications are now open for the AHA Rural Hospital Excellence in Innovation Award, which recognizes and shares the accomplishments of rural hospitals that demonstrate responsiveness, innovation and excellence in developing, implementing and sustaining programs and services.
The Food and Drug Administration April 28 announced its plan to advance the implementation of real-time clinical trials, which invite participants to supply reports and data to the agency during the approved clinical trials rather than at completion.
The AHA submitted a statement for the record to the House Ways and Means Committee for its April 28 hearing with health system CEOs.
The Food and Drug Administration has identified a nationwide recall.
The AHA Leadership Summit will be held July 12-14 in Denver.
The AHA again is asking the Health Resources and Services Administration to take action after Eli Lilly warned hospitals that they could lose access to discounted drug prices unless they comply with new data submission requirements.
The Utah measles outbreak has increased to 607 cases, the state’s Department of Health and Human Services reported April 24.